These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 78851)
1. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors. Gomard E; Levy JP; Plata F; Henin Y; Duprez V; Bismuth A; Reme T Eur J Immunol; 1978 Apr; 8(4):228-36. PubMed ID: 78851 [No Abstract] [Full Text] [Related]
2. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
3. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells. Sensi ML; Parenza M; Parmiani G J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938 [TBL] [Abstract][Full Text] [Related]
4. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice. Plater C; Debré P; Leclerc JC Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278 [TBL] [Abstract][Full Text] [Related]
5. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells. Brunner KT; MacDonald HR; Cerottini JC J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076 [No Abstract] [Full Text] [Related]
6. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor. Wilson A; Shortman K Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835 [TBL] [Abstract][Full Text] [Related]
7. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. Green WR J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413 [No Abstract] [Full Text] [Related]
8. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor. Wiltrout RH; Frost P J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255 [No Abstract] [Full Text] [Related]
9. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo. Lake P; Sabbadini E; Sehon AH Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936 [TBL] [Abstract][Full Text] [Related]
10. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. Green WR; Nowinski RC; Henney CS J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211 [No Abstract] [Full Text] [Related]
11. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro. Ryser JE; Cerottini JC; Brunner KT Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224 [TBL] [Abstract][Full Text] [Related]
12. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL. Schirrmacher V; Garrido F; Hübsch D; Garcia-Olivares E; Koszinowski U Transplant Proc; 1980 Mar; 12(1):32-7. PubMed ID: 6154357 [No Abstract] [Full Text] [Related]
13. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice. Fuyama S; Yamamoto H; Fujii Y; Arai S Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480 [TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223 [TBL] [Abstract][Full Text] [Related]
15. Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. Young WW; Hakomori SI; Durdik JM; Henney CS J Immunol; 1980 Jan; 124(1):199-201. PubMed ID: 6985637 [TBL] [Abstract][Full Text] [Related]
16. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
17. [Production of heterologous antibodies to T-killers of mice immunized against H-2 antigens]. Egorova SG; Gritsman AIu; Brondz BD Biull Eksp Biol Med; 1980 Jul; 89(7):62-4. PubMed ID: 6157432 [TBL] [Abstract][Full Text] [Related]
18. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes. Plata F; Jongeneel CV J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025 [No Abstract] [Full Text] [Related]
19. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system. Gjedde SB Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250 [TBL] [Abstract][Full Text] [Related]
20. The induction of cytolytic T lymphocytes with purified plasma membranes. Lemonnier F; Mescher TM; sherman L; Burakoff S J Immunol; 1978 Apr; 120(4):1114-20. PubMed ID: 76660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]